Finally, T2DM is strongly correlated with the loss of the incretin effect due to a reduction in gastric inhibitory polypeptide (GIP) and glucagon-like peptide 1 (GLP1) secretion from the gut [24]. The gene discussed is GIP; the disease is type 2 diabetes mellitus.